The firs t case of synovia l sarco ma of the head and neck was described by Jernstrom in 1954. 3 In thi s article , we report a new case of synovial sarcoma that origina ted in the posterior pharyngeal wall in a child.
Introduction
A synovial sarcoma is a malignant tum or made up of primitive pluripotential mesenchymal cells . It is responsible for approximately 10% of all soft-tiss ue sarco mas.' > Th ese tumors are usually encountered in the periarticular areas of the lower extremities; only about 10% of cases occ ur in the head and neck region. I The firs t case of synovia l sarco ma of the head and neck was described by Jernstrom in 1954. 3 In thi s article , we report a new case of synovial sarcoma that origina ted in the posterior pharyngeal wall in a child.
Case report
A 14-year-old girl came to us with a 3-month history of progressive breathing difficult y and dysph agia. She had a muffl ed voice but was in no apparent res piratory distress. Physical exa mination revealed the presence of a midl ine submucosal mass in the posterior pha ryngeal wa ll that ex tende d from the nasoph arynx down to the level of the epig lottis. Findings on examination of the neck were norm al. Contrast-enhanced computed tomography (CT) revealed the presence of a nonh om ogenous mass that was prim arily made up of cystic co mpo nents; in addition, some solid co mponents were sca ttere d throughout the parenchyma (fig ure I) . Th e mass was cle arly surrounded by a thin capsule at all levels. Despit e the close proximity of the mass to the major neck vesse ls, no vesse l involvement was observed. We did not perform a preoperative biopsy because the lesion ' s location might have led to airway probl em s.
After discussing various treatment options with the patient and her fami ly, we decided on excision via a transoral approac h with a possible midline mandibul otomy and tracheotom y. We were able to adequately expose the mass with a soft-pa late retractor and a Jensen ' s tongue retractor. Afterestablishing a submucosa l dissection plane, we com pletely removed the mass and its entire capsule transorally.
Th e postopera tive per iod was uneve ntfu l, and there was no need for the trach eotomy. The path ologist reported a synov ial sarco ma. An extensive postoperative searc h for distant metastases was negative. Two represe ntative sections of a hematoxylin-and-eosin-stained spec imen revea led biph asic cellular ity (figure 2). Immunohistochemistry was positive for cytokeratin (fig ure 3) . The patient underwent postoperative irradiation to 60 Gy, and she was free of rec urrent and distant metastatic disease at the 40-mo nth follow-up (fig ure 4) .
Discussion
Synovial sarco ma is a malignant soft-tissue neoplasm that arises from primi tive pluripotential mese nchy mal cells near to or remote from articular surfaces. Oth er terms used to describ e this entity are synovial cell sarco ma and malignant synoviomaP Although the term synovioma implies a benign co ndition, further investigatio ns have Incidence. Synovi al sarcomas acco unt for 8 to 10% of all sarcomas. I Alth ough these tum ors occur predominantl y in the extremities, they are also know n to arise in the head and neck region.' Since the first description of a head and neck synovial sarco ma by Jernstrom? in 1954, fewer than 100 cases have been reported in the literature, and they account for 3 to 10% of all reported cases. ' Clinical characteristics. The most common site of synovial sarco ma of the head and neck is the hypopharynx. 4 • 6 These tumors have been encountered in other areas of the head and neck as well, including preve rtebral and parapharyngeal areas and maxillofacial , pharyngeal, and laryngeal sites.' Syn ovial sarcomas have a male preponderance (3:2) and a predilection for patients between the ages of25 and 36 years." Patients with synovial sarco ma of the head and neck tend to be younge r than those who have such tumors in the extre mities . "
The tumor usually appears as an asymptomatic mass until it attains sufficient volume to cause pressure effects on neighboring structures . This process is usually more rapid in patients with head and neck synovial sarcoma than in those whose tumor is in an extremity. Lockey reported that patients with head and neck tumors were diagnosed an average of 20 month s earlier than those with extre mity tumors."This slower grow th rate (and perhaps the resultant lower rate of lymph node metastasis) might explain why head and neck patients have a better prognosis.
Histologic characteristics. Although monophasic forms of synovial sarcoma have been reported , its primary histopathologic feature is biphasic cellularity (figure 2). 10 Microscopically, the tum or is made up of epithelial and sarcomatous components. The glandular appearance created by epithelial malignancy can mislead the pathol ogist to a diagnosis of a salivary gland tumor. Likewise, its sarcomatous structure can lead to an incorrect diagnosis of a malignant schwa nnoma or fibrosa rco ma. Immunohistochemi stry is key to a definitive diag nosis. Th e mon oph asic form exhibits prima rily sarcomatous features; the monophasic epithelial form is rare.
Treatment. The relatively small numb er of patients with synovial sarcoma of the head and neck precludes us from drawing firm conclu sion s with respect to a precise treatm ent protocol. For now , the primary mode of treatment is wide surgical excision that includ es a norm alappearing tissue cuff in order to obtain tumor-negative margins. However, this cannot always be acco mplis hed in head and neck cases because of the proximit y ofthe tumor to vital structures.
The results of multimodality treatment appear to be better than those seen with any single-modality treatment 
• »t ,

Medical Technologies Corporation
For more information Circle 112 on Reader Service C ard
